Sort
23,748 grants matching “melanoma”
Statewide Cancer Data
$316,072Andrew Olshan · Univ Of North Carolina Chapel Hill · P30 · FY2025 · CA
Developmental Regulation of Gene Expression by Long Undecoded Transcript Isoforms
$316,060Elcin Unal · University Of California Berkeley · R01 · FY2022 · GM
Apoptosis of skin melanoma by the new Hsp H11
$316,050Laure Aurelian · University Of Maryland Baltimore · R01 · FY2009 · AR
Apoptosis of skin melanoma by the new Hsp H11
$316,050Laure Aurelian · University Of Maryland Baltimore · R01 · FY2008 · AR
NHGRI/DIR Microarray Core
$316,036Abdel Elkahloun · National Human Genome Research Institute · ZIC · FY2014 · HG
Combining targeted radionuclide therapy with a localized in situ vaccine to overcome immune suppression in the tumor microenvironment and augment T cell responses
$316,027Paul M Sondel · University Of Wisconsin-Madison · P01 · FY2022 · CA
Role of PKC in Tumor Promotion
$316,003Ajit K Verma · University Of Wisconsin-Madison · R01 · FY2011 · CA
Tumor induced senescent and suppressor T cells - a novel mechanism of immune evas
$316,002Brian R Gastman · Cleveland Clinic Lerner Com-Cwru · R01 · FY2012 · CA
Bone Marrow MSCs/Pericytes: Gatekeepers Controlling Skeletal Metastasis.
$316,002Arnold I. Caplan · Case Western Reserve University · R01 · FY2014 · CA
Targeting MFG-E8 as Melanoma Immunotherapy
$316,002Glenn Dranoff · Dana-Farber Cancer Inst · R01 · FY2011 · CA
Tumor induced senescent and suppressor T cells - a novel mechanism of immune evas
$316,002Brian R Gastman · Cleveland Clinic Lerner Com-Cwru · R01 · FY2011 · CA
Targeting MFG-E8 as Melanoma Immunotherapy
$316,002Glenn Dranoff · Dana-Farber Cancer Inst · R01 · FY2012 · CA
VISTA, a novel checkpoint that suppresses anti-tumor T cell responses
$315,981Li Lily Wang · Dartmouth College · R01 · FY2013 · CA
Project 1: Tropical Plants Biological Testing
$315,976Alan Douglas Kinghorn · Ohio State University · P01 · FY2024 · CA
Designing Lymph Nodes for Cancer Immunotherapy
$315,961James J Mule · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2013 · CA
Novel focused ultrasound enhanced calreticulin-nanoparticle for immune primed melanoma immunotherapy
$315,862Ashish Ranjan · Oklahoma State University Stillwater · R37 · FY2020 · CA
Cancer and Stroma-Targeted Immunotherapy with a Gentically Modified DC Vaccine
$315,831Xiaotong Song · Baylor College Of Medicine · R01 · FY2014 · CA
Project 4: Immunovirotherapy
$315,793Richard G Vile · Mayo Clinic Rochester · P50 · FY2020 · CA
ONCOGENE MEDIATED CHANGES IN CELL CYCLE CONTROL
$315,694Massachusetts General Hospital · R01 · FY2000 · CA
INHIBITION OF THE ANTICANCER TARGET GLYOXALASE I
$315,682University Of Maryland Balt Co Campus · R01 · FY2003 · CA
Intratumoral injection of a-gal glycolipids in stage IV melanoma: Phase I Trial
$315,624Uri Galili · Univ Of Massachusetts Med Sch Worcester · R21 · FY2009 · CA
Papillomavirus E2 Functions: Cellular Regulation and Effectors
$315,608Peter M Howley · Harvard Medical School · R01 · FY2012 · CA
CELLULAR ACTIVATION MECHANISMS INDUCED BY MITOGENS
$315,569Jiing-Dwan Lee · Scripps Research Institute, The · R01 · FY2010 · CA
CELLULAR ACTIVATION MECHANISMS INDUCED BY MITOGENS
$315,569Jiing-Dwan Lee · Scripps Research Institute, The · R01 · FY2009 · CA
CELLULAR ACTIVATION MECHANISMS INDUCED BY MITOGENS
$315,569Jiing-Dwan Lee · Scripps Research Institute, The · R01 · FY2008 · CA